Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.78 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.78 |
| ▸ | HPGD | P15428 | 3/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.78 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.78 |
| ▸ | PDE4A | P27815 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.78 |
| ▸ | KCNA3 | P22001 | 2/20 | 0.59 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Khellin SCHEMBL9655 | 0.88 | CYP3A4 (1.00) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| Khellin SCHEMBL30839911 | 0.88 | CYP3A4 (1.00) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| SCHEMBL3609628 | 0.86 | CYP3A4 (0.82) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| SCHEMBL1341546 | 0.85 | CYP3A4 (0.55) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| SCHEMBL1344606 | 0.84 | CYP3A4 (0.78) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| SCHEMBL12133302 | 0.84 | CYP3A4 (0.56) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| SCHEMBL10300855 | 0.83 | CYP3A4 (0.53) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| SCHEMBL10300858 | 0.83 | ALDH1A1 (0.56) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| SCHEMBL4037947 | 0.82 | CYP3A4 (0.56) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 | |
| SCHEMBL13920849 | 0.81 | CYP3A4 (0.81) | CYP3A4CYP1A1HPGDMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11083197-B2 | Herbicidal composition comprising chromone derivatives and a method for weed control | Investigaciones Biologicas en Agroquimicos Rosario S.A. (AR) | 2021-08-10 | — | — | US | claimed |
| US-20190021328-A1 | HERBICIDAL COMPOSITION COMPRISING CHROMONE DERIVATIVES AND A METHOD FOR WEED CONTROL | INVESTIGACIONES BOLÓGICAS EN AGROQUIMICOS ROSARIO S.A. (AR) | 2019-01-24 | — | — | US | claimed |
| EP-3397056-A1 | HERBICIDAL COMPOSITION COMPRISING CHROMONE DERIVATIVES AND A METHOD FOR WEED CONTROL | Investigaciones Biológicas en Agroquimicos Rosario S.A. (AR) | 2018-11-07 | — | — | EP | claimed |
| WO-2017115333-A1 | HERBICIDAL COMPOSITION COMPRISING CHROMONE DERIVATIVES AND A METHOD FOR WEED CONTROL | INVESTIGACIONES BIOLÓGICAS EN AGROQUÍMICOS ROSARIO S.A. (AR) | 2017-07-06 | — | — | WO | claimed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-20240216456-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216457-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240207344-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240207342-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240108676-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-04-04 | — | — | US | disclosed |
| US-11883454-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2024-01-30 | — | — | US | disclosed |
| US-20080221194-A1 | Novel Potassium channel Blockers and Uses Thereof | HARVEY ANDREW J | 2008-09-11 | — | — | US | disclosed |
| US-20080221194-A1 | Novel Potassium channel Blockers and Uses Thereof | HARVEY ANDREW J | 2008-09-11 | — | — | US | disclosed |
| WO-2006096911-A1 | NOVEL POTASSIUM CHANNEL BLOCKERS AND USES THEREOF | HARVEY ANDREW J (AU) | 2006-09-21 | — | — | WO | disclosed |
| EP-0303920-B1 | BENZOFURAN DERIVATIVES AND THERAPEUTIC AGENTS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1992-03-18 | — | — | EP | disclosed |
| EP-0284914-B1 | BENZOFURAN DERIVATIVES AND THERAPEUTIC AGENTS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
| US-4845096-A | Benzofuran derivatives and antiulcerogenic agents containing same | BASF AKTIENGSELLSCHAFT (DE) | 1989-07-04 | — | — | US | disclosed |
| EP-0303920-A1 | Benzofuran derivatives and therapeutic agents containing them | BASF Aktiengesellschaft (DE) | 1989-02-22 | — | — | EP | disclosed |
| EP-0284914-A1 | Benzofuran derivatives and therapeutic agents containing them | BASF Aktiengesellschaft (DE) | 1988-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11083197-B2 | Herbicidal composition comprising chromone derivatives and a method for weed control | CBR3, CYP4B1, CHRM1 | CYP3A4 38/4885CYP1A1 12/4885HPGD 951/4885 |
| US-20190021328-A1 | HERBICIDAL COMPOSITION COMPRISING CHROMONE DERIVATIVES AND A METHOD FOR WEED CONTROL | CBR3, CYP4B1, CHRM1 | CYP3A4 38/4885CYP1A1 12/4885HPGD 951/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | CYP3A4 1979/4885CYP1A1 2153/4885HPGD 1580/4885 |
| US-20080221194-A1 | Novel Potassium channel Blockers and Uses Thereof | KCNAB1, KCNB1, KCNMB1 | CYP3A4 2095/4885CYP1A1 1790/4885HPGD 3279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.